Ultrasonographic measures of synovitis in an early phase clinical trial: a double-blind, randomised, placebo and comparator controlled phase IIa trial of GW274150 (a selective inducible nitric oxide synthase inhibitor) in rheumatoid arthritis.

Ultrasonographic measures of synovitis in an early phase clinical trial: a double-blind, randomised, placebo and comparator controlled phase IIa trial of GW274150 (a selective inducible nitric oxide synthase inhibitor) in rheumatoid arthritis.

OBJECTIVES: To test the sensitivity to change of ultrasonographic endpoints in early phase clinical trials in subjects with active rheumatoid arthritis (RA). METHODS: A double-blind, placebo and comparator controlled, randomised, two-centre study investigated the effect on synovial thickness and va...

Podrobná bibliografie
Hlavní autoři:	Seymour, M, Pétavy, F, Chiesa, F, Perry, H, Lukey, P, Binks, M, Donatien, P, Freidin, A, Eckersley, R, McClinton, C, Heath, K, Prodanovic, S, Radunovic, G, Pilipovic, N, Damjanov, N, Taylor, P
Médium:	Journal article
Jazyk:	English
Vydáno:	2012

Podobné jednotky

Between-group differences in ultrasonographic measures of synovitis and kinetics of response to oral steroids in active RA
Autor: Larche, M, a další
Vydáno: (2006)

The effect of the potent and selective iNOS (NOS-2) inhibitor GW274150 in models of acute and establised inflammatory and neuropathic pain in the rat
Autor: Clayton, N, a další
Vydáno: (2000)

Quantitative power Doppler ultrasonography is a sensitive measure of metacarpophalangeal joint synovial vascularity in rheumatoid arthritis and declines significantly following a 2-week course of oral low-dose corticosteroids.
Autor: Larché, M, a další
Vydáno: (2010)

Colorectal distension-evoked iNOS, nitrotyrosine and C-FOS expression in the anaesthetised rat is inhibited by the selective iNOS inhibitor GW274150
Autor: Clayton, N, a další
Vydáno: (2001)

B-LYMPHOCYTE chemoattractant (BLC/CXCL13): A potential novel disease activity marker of rheumatoid arthritis
Autor: Pastor, I, a další
Vydáno: (2007)

A phase Ib/IIa clinical trial of dantrolene sodium in patients with Wolfram syndrome
Autor: Damien Abreu, a další
Vydáno: (2021-08-01)

Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
Autor: R. C. Coombes, a další
Vydáno: (2022-06-01)

A human phase I/IIa malaria challenge trial of a polyprotein malaria vaccine
Autor: Porter, D, a další
Vydáno: (2011)

A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine.
Autor: Porter, D, a další
Vydáno: (2011)

Health behaviour changes in partners of women with recent gestational diabetes: a phase IIa trial
Autor: Anne-Sophie Brazeau, a další
Vydáno: (2018-05-01)

A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results
Autor: Matthew Winter, a další
Vydáno: (2022-08-01)

P15-01. Willingness to participate in actual preventive HIV vaccine phase I/IIa trial in Bangkok, Thailand
Autor: Phanuphak P, a další
Vydáno: (2009-10-01)

Power to identify exposure‐response relationships in phase IIa pulmonary tuberculosis trials with multi‐dimensional bacterial load modeling
Autor: Simon E. Koele, a další
Vydáno: (2024-03-01)

Is painless synovitis different from painful synovitis? A controlled, ultrasound, radiographic, clinical trial
Autor: Daniele Freitas Pereira, a další

Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.
Autor: Thompson, F, a další
Vydáno: (2008)

Evaluation of new or repurposed treatments for COVID-19: protocol for the phase Ib/IIa DEFINE trial platform
Autor: Ahsan Akram, a další
Vydáno: (2021-12-01)

Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Autor: Joon Oh Park, a další
Vydáno: (2024-08-01)

Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.
Autor: Fiona M Thompson, a další
Vydáno: (2008-01-01)

Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial.
Autor: Johannes M van Noort, a další
Vydáno: (2015-01-01)

Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
Autor: Senti, G, a další
Vydáno: (2009)

Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
Autor: R. C. Coombes, a další
Vydáno: (2023-01-01)

Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial
Vydáno: (2011-01-01)

Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial.
Autor: Fiona M. Thompson, a další
Vydáno: (2011-01-01)

Transplantation of Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial
Autor: Eva Syková M.D., Ph.D., Dr.Sc., a další
Vydáno: (2017-04-01)

Comparison of ultrasonographic measures of synovitis and radiographic assessment of structural damage over two years in a randomised, controlled trial of infliximab therapy in erosive early rheumatoid arthritis.
Autor: Taylor, P, a další
Vydáno: (2004)

STudy of Alteplase for Respiratory failure in SARS‐Cov2/COVID‐19: Study Design of the Phase IIa STARS Trial
Autor: Moore, Hunter B., a další
Vydáno: (2020)

A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.
Autor: Scriba, T, a další
Vydáno: (2012)

Elritercept, a modified activin receptor IIA ligand trap, increased erythropoiesis and thrombopoiesis in a phase 1 trial
Autor: Jennifer Lachey, a další
Vydáno: (2025-01-01)

Selective Inhibition of the MK2 Pathway: Data From a Phase IIa Randomized Clinical Trial in Rheumatoid Arthritis
Autor: David Gordon, a další
Vydáno: (2023-02-01)

Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial
Autor: I’ah Donovan-Banfield, a další
Vydáno: (2022-11-01)

NGlycolylGM3/VSSP Vaccine in Metastatic Breast Cancer Patients: Results of Phase I/IIa Clinical Trial
Autor: Ana de la Torre, a další
Vydáno: (2012-09-01)

DON in pediatric cerebral malaria, a phase I/IIA dose-escalation safety study: study protocol for a clinical trial
Autor: Nginache Nampota-Nkomba, a další
Vydáno: (2024-01-01)

Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial
Autor: Andreas Kerstan, a další
Vydáno: (2022-01-01)

A feasibility and safety study of afamelanotide in acute stroke patients – an open label, proof of concept, phase iia clinical trial
Autor: Vimal Stanislaus, a další
Vydáno: (2023-07-01)

Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic)
Autor: Mohamed Hamidou, a další
Vydáno: (2021-03-01)

RIVA – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial
Autor: Sean H. Lim, a další
Vydáno: (2018-11-01)

STROKE34 Study Protocol: A Randomized Controlled Phase IIa Trial of Intra-Arterial CD34+ Cells in Acute Ischemic Stroke
Autor: João Sargento-Freitas, a další
Vydáno: (2018-05-01)

The PACOVAR-trial: A phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer
Autor: Schmidt Marcus, a další
Vydáno: (2011-10-01)

Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trial
Autor: Julian R Marchesi, a další
Vydáno: (2024-12-01)

Efficacy of the novel Plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial
Autor: Minassian, A, a další
Vydáno: (2018)